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Physicists have particle accelerators, 
structural biologists have 
synchrotrons, and astronomers have 
radio telescopes. Pity molecular 
biologists, stuck thinking that a PCR 
machine, a glorified heating block, is 
the height of technological innovation. 
Help is at hand in the form of 
Caliper Technologies Corp. (Palo 
Alto, California). Caliper is one of 
several young companies putting 
microfluidic versions of your favorite 
laboratory procedure onto glass or 
plastic chips. The tiny channels on 
the chips can withstand 
proportionately huge voltage 
differences, so standard procedures 
whip by: perhaps a minute for a DNA 
fragment separation or a few seconds 
for an enzyme assay. The devices 
could also revolutionize both medical 
diagnostics and high-throughput 
screening of drug candidates. 
Goodbye test tubes 
“If you go through a standard 
laboratory it is unbelievably 
primitive,” says Michael Knapp, Vice 
President for Science and Technology 
at Caliper. “So we looked around for 
alternatives to the standard test tubes 
and beakers and pipettes.” The 
Caliper team found their vision of the 
future in the form of J. Michael 
Ramsey of Oakridge National 
Laboratory in Tennessee. Ramsey had 
started with capillary electrophoresis 
(CE), which is used for the separation 
of small molecules that diffuse too 
rapidly when standard, slower 
separation techniques are used. 
Although CE had never replaced 
common and simple techniques such 
as agarose gels, Knapp felt that with 
Ramsey’s innovations such a takeover 
was possible. 
Ramsey and others had made a 
long-awaited mental leap from 
biology to materials science. The 
necessary micromachining methods 
had been devised decades ago for 
computer chips, and the new 
experimental concept was simple: by 
placing CE on a glass chip the 
researchers defined the logic of their 
experiment (Figure 1). “You can 
create a device of arbitrary complexity 
that can become the instruction set of 
an experiment,” says Knapp. 
The basic technique of molecular 
biology - the endless movement of 
colorless liquids - is what the new 
chips do best. Each reservoir on a 
chip is a source of buffer, enzyme, 
substrate, inhibitor or DNA, or a sink 
for waste. Fluid movement out of a 
reservoir occurs by electro-osmosis, a 
phenomenon from the world of CE 
in which ions associated with the 
channel surface move in response to 
a voltage change, and drag bulk fluid 
with them because of viscous drag. 
Voltage changes are used to first 
bring reactants together by electro- 
osmosis, and then separate products 
by electrophoresis. Valves are simply 
the channel junctions: Control of the 
voltage from all four directions can 
keep a liquid trapped between 
junctions, or flowing straight or 
around a corner (Figure 2). 
Coming soon to a lab near you 
The Caliper machine that runs the 
chips has the color, size and lines of a 
Macintosh computer. “You can 
imagine putting it on your desktop 
and a scientist will look like any other 
office worker,” says George Church 
(Harvard Medical School, Boston, 
Massachusetts, and a member of 
Caliper’s scientific advisory board). 
But this box - dubbed the Macarena 
- contains both electronics and a 
confocal optical system using laser- 
induced fluorescence.The 
-2 cm x 2 cm glass chip is inserted on 
the top of the machine, slotting into 
Figure 1 
The layout of a Caliper chip. Voltage changes 
at the reservoirs, seen here as large circles, 
cause fluid to move into the microchannels, 
which in this image are filled with a red dye. 
Channel junctions act as valves, and 
stretches of channels between junctions can 
act as reaction chambers or separation 
columns. Image courtesy of Caliper. 
the 16 pins that control voltage levels 
in the reservoirs. The Macarena is 
scheduled for release towards the end 
of 1998. Pricing has not been set, but 
Knapp says the box “need not cost 
much more than $10,000, and the 
chips need only be a few dollars each.” 
“The function is dependent on the 
chip you put in there; it becomes a 
personal laboratory,” says Knapp. 
“The Macarena is almost a peripheral: 
it’s a way of getting information about 
chemicals into a computer.” Possible 
functions include DNA separations, 
sequencing, PCR, receptor binding, 
enzyme inhibition, and immunoassays. 
The delay in releasing the 
Macarena is more about developing a 
marketing plan than developing the 
product. Caliper faces a cultural 
challenge in convincing thousands of 
molecular biologists to trade in their 
trusty electrophoresis boxes and 
racks of eppendorf tubes. 
Church, for one, is ready for the 
Macarena. “I think it will be like 
mini-gels,” he says. “People realized 
they were inexpensive, didn’t take 
up much space, and broke down the 
inertia barrier of running a gel. This 
takes the process one step further.” 
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Figure 2 
The Macarena was designed, says 
Knapp, to do standard techniques but 
to do more of them faster. But that 
may be enough to translate into new 
protocols. “A lot of things are possible 
with current methods, but just very 
difficult and expensive,” says Church. 
With the Macarena, he says, “maybe 
there will be a feedback loop, so you 
can re-run experiments. If that 
involved reconnecting machines you 
would be reluctant to do it. You 
wouldn’t try out ten protocols a day 
for 100 days. With this you could.” 
“One of the promises is great 
integration, where you have a 
number of steps dovetailed 
together,” says Church. For example, 
both Caliper and Soane Biosciences 
(Hayward, California) have 
successfully combined PCR followed 
by electrophoresis and product 
detection. All this, on a single chip 
and with no human intervention, 
takes less than 20 minutes. The 
results come out as clean peaks on a 
computer screen. 
For ion-exchange or affinity 
chromatography the channels can be 
filled with beads. The packing is no 
easy task, so PerSeptive Biosystems, 
Inc. (Framingham, Massachusetts) 
has replaced the beads with etched 
cubes of silicon. The cubes are 
evenly spaced, never move, and are 
easy to make: etching thousands of 
objects on one chip involves the 
same amount of work as etching one 
object. Deep etching reduces back 
pressure sufficiently to allow high- 
pressure liquid chromatography. 
A small drug company in a room 
Soane and Caliper are both planning 
to screen large libraries of chemicals 
against drug targets for pharmaceutical 
companies. Constraining small 
molecules for the time needed to do 
cell-based assays is a challenge, but a 
Caliper scientist states this is “an 
engineering problem rather than a 
theoretical limitation.” Simpler 
protein-based assays will start in the 
next few months, with a different 
compound sent into the Caliper 
system every few seconds. “You could 
assemble warehouses of equipment 
and get to that throughput, but it 
would cost too much,” says Knapp. 
Caliper does not plan on 
becoming a drug company, however. 
“We’re pursuing more or less an Intel 
strategy - we’re focusing on making 
the chips, not on becoming a 
diagnostics or pharmaceutical 
company,” says Knapp. 
The companies most interested 
in diagnostics are Micronics, Inc. 
(Redmond, Washington) and 
Cepheid (Santa Clara, California). 
The concerns in this area are 
somewhat different. “There is a lot 
of hype about handling picoliters of 
fluids,” says Kurt Petersen, President 
of Cepheid. “In diagnostics that is 
not the point.” Cepheid has used 
deep reactive ion etching to increase 
the depth of the channels and so the 
amount of material that can be tested 
for pathogens or biowarfare agents. 
Keeping the cost of the disposable 
chips low is particularly important in 
diagnostics, so plastics are the 
preferred material. “This is a 
traditional razor/razor blade 
technology,” says Tom Schulte, Vice 
President of Research and 
Development at Micronics. “The 
razor blade must be made for a cost 
where we can make money.” 
Micronics will release a prototype 
disposable cartridge in the next few 
months, with a final product launch 
in mid-2000. The diagnostic machine 
will cost -$lZ,OOO, says Schulte, and 
the cartridges will cost less than $2 
each. Blood in a syringe is injected 
directly into a cap at one end and 
moves into the credit-card-sized 
plastic device. The results, including 
a platelet count, red blood cell count, 
and hemoglobin levels, are all 
reported in 2.5 minutes. 
Both companies must convince 
private medical insurers in the United 
States that centralized testing services 
can be distributed into doctors’ 
offices. “The market for diagnostics is 
not limited simply by technology,” 
says Knapp. “But if you look 1000 
years from now, do you really think 
you will send a blood sample to 
Teterboro, New Jersey?” 
The first test market will, 
however, probably be the research 
community. Church is anxious for the 
machines’ release. “It’s like a brand 
new piece of Intel hardware: you 
need to get it out there for people to 
write cool software,” he says. “This is 
a blank sheet of paper.” 
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